(NASDAQ: XCUR) is trading higher on news of $5million private placement places at premium to market. Money raised to support advancement of pre-clinical candidates.  Shares are up 40% on increasing volume as the stock still trades below a dollar.

Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premium

Proceeds expected to support Exicures continued advancement of preclinical candidates including its SCN9A product candidate, a non-opioid pain analgesic


  • The private placement is being led by a subsidiary of CBI Co., Ltd. (CBI), a member of a leading investment group in South Korea focusing on science-based companies in South Korea and the United States

CHICAGO–(BUSINESS WIRE)–
Exicure, Inc. (NASDAQ:XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that it has agreed to sell an aggregate of 26,021,111 shares of its common stock at a purchase price of $0.1937 per share to certain accredited investors in a private placement in public equity (PIPE) financing. The purchase price of $0.1937 per share of common stock represents an approximately 45% premium to the 10-day volume weighted-average share price from May 9, 2022. Exicure anticipates that the gross proceeds from the PIPE will be approximately $5 million, before deducting transaction-related expenses payable by the Company. The Company intends to use the net proceeds from this offering to support the development of the advancement of its preclinical program, including the development of its SCN9A product candidate, as well as other working capital and general corporate purposes.

Read entire article here: https://www.businesswire.com/news/home/20220510006499/en/Exicure-Announces-5-Million-Raise-in-Private-Placement-Transaction-Priced-at-Market-Premium

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist